BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28280090)

  • 1. Pooled Clustering of High-Grade Serous Ovarian Cancer Gene Expression Leads to Novel Consensus Subtypes Associated with Survival and Surgical Outcomes.
    Wang C; Armasu SM; Kalli KR; Maurer MJ; Heinzen EP; Keeney GL; Cliby WA; Oberg AL; Kaufmann SH; Goode EL
    Clin Cancer Res; 2017 Aug; 23(15):4077-4085. PubMed ID: 28280090
    [No Abstract]   [Full Text] [Related]  

  • 2. Epigenetic Reprogramming Strategies to Reverse Global Loss of 5-Hydroxymethylcytosine, a Prognostic Factor for Poor Survival in High-grade Serous Ovarian Cancer.
    Tucker DW; Getchell CR; McCarthy ET; Ohman AW; Sasamoto N; Xu S; Ko JY; Gupta M; Shafrir A; Medina JE; Lee JJ; MacDonald LA; Malik A; Hasselblatt KT; Li W; Zhang H; Kaplan SJ; Murphy GF; Hirsch MS; Liu JF; Matulonis UA; Terry KL; Lian CG; Dinulescu DM
    Clin Cancer Res; 2018 Mar; 24(6):1389-1401. PubMed ID: 29263182
    [No Abstract]   [Full Text] [Related]  

  • 3. Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes.
    Barnes BM; Nelson L; Tighe A; Burghel GJ; Lin IH; Desai S; McGrail JC; Morgan RD; Taylor SS
    Genome Med; 2021 Sep; 13(1):140. PubMed ID: 34470661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA2 and high-grade serous ovarian carcinoma.
    Wu J; Wei JJ
    J Mol Med (Berl); 2013 Oct; 91(10):1155-65. PubMed ID: 23686260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress.
    Cesaratto L; Grisard E; Coan M; Zandonà L; De Mattia E; Poletto E; Cecchin E; Puglisi F; Canzonieri V; Mucignat MT; Zucchetto A; Stocco G; Colombatti A; Nicoloso MS; Spizzo R
    Cell Death Dis; 2016 Sep; 7(9):e2374. PubMed ID: 27899818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model.
    Kleinmanns K; Fosse V; Davidson B; de Jalón EG; Tenstad O; Bjørge L; McCormack E
    EBioMedicine; 2020 Jun; 56():102783. PubMed ID: 32454402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the prognostic potential of histopathological subtyping in high-grade serous ovarian carcinoma.
    Zelisse HS; Hwan RA; van de Vijver MJ; Dijk F; Mom CH; Hooijer GKJ; van Gent MDJM; Snijders MLH
    Virchows Arch; 2024 Apr; ():. PubMed ID: 38622323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathologic image-based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer.
    Ahn B; Moon D; Kim HS; Lee C; Cho NH; Choi HK; Kim D; Lee JY; Nam EJ; Won D; An HJ; Kwon SY; Shin SJ; Jung HR; Kwon D; Park H; Kim M; Cha YJ; Park H; Lee Y; Noh S; Lee YM; Choi SE; Kim JM; Sung SH; Park E
    Nat Commun; 2024 May; 15(1):4253. PubMed ID: 38762636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commonly Occurring Cell Subsets in High-Grade Serous Ovarian Tumors Identified by Single-Cell Mass Cytometry.
    Gonzalez VD; Samusik N; Chen TJ; Savig ES; Aghaeepour N; Quigley DA; Huang YW; Giangarrà V; Borowsky AD; Hubbard NE; Chen SY; Han G; Ashworth A; Kipps TJ; Berek JS; Nolan GP; Fantl WJ
    Cell Rep; 2018 Feb; 22(7):1875-1888. PubMed ID: 29444438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Piezo1 mechanotransduction in high-grade serous ovarian cancer: Insights from an in vitro model of collective detachment.
    Micek HM; Yang N; Dutta M; Rosenstock L; Ma Y; Hielsberg C; McCord M; Notbohm J; McGregor S; Kreeger PK
    Sci Adv; 2024 Apr; 10(17):eadl4463. PubMed ID: 38669327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Claudin-Low Subtype of High-Grade Serous Ovarian Carcinoma Exhibits Stem Cell Features.
    Romani C; Capoferri D; Grillo E; Silvestri M; Corsini M; Zanotti L; Todeschini P; Ravaggi A; Bignotti E; Odicino F; Sartori E; Calza S; Mitola S
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33671478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel representation of inter-site tumour heterogeneity from pre-treatment computed tomography textures classifies ovarian cancers by clinical outcome.
    Vargas HA; Veeraraghavan H; Micco M; Nougaret S; Lakhman Y; Meier AA; Sosa R; Soslow RA; Levine DA; Weigelt B; Aghajanian C; Hricak H; Deasy J; Snyder A; Sala E
    Eur Radiol; 2017 Sep; 27(9):3991-4001. PubMed ID: 28289945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular subtypes of high-grade serous ovarian cancer across racial groups and gene expression platforms.
    Davidson NR; Barnard ME; Hippen AA; Campbell A; Johnson CE; Way GP; Dalley BK; Berchuck A; Salas LA; Peres LC; Marks JR; Schildkraut JM; Greene CS; Doherty JA
    Cancer Epidemiol Biomarkers Prev; 2024 May; ():. PubMed ID: 38780898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular subtypes of high-grade serous ovarian cancer across racial groups and gene expression platforms.
    Davidson NR; Barnard ME; Hippen AA; Campbell A; Johnson CE; Way GP; Dalley BK; Berchuck A; Salas LA; Peres LC; Marks JR; Schildkraut JM; Greene CS; Doherty JA
    bioRxiv; 2023 Dec; ():. PubMed ID: 37961178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens.
    Hunt AL; Bateman NW; Barakat W; Makohon-Moore S; Hood BL; Conrads KA; Zhou M; Calvert V; Pierobon M; Loffredo J; Litzi TJ; Oliver J; Mitchell D; Gist G; Rojas C; Blanton B; Robinson EL; Odunsi K; Sood AK; Casablanca Y; Darcy KM; Shriver CD; Petricoin EF; Rao UNM; Maxwell GL; Conrads TP
    iScience; 2021 Jul; 24(7):102757. PubMed ID: 34278265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium.
    Minlikeeva AN; Freudenheim JL; Cannioto RA; Szender JB; Eng KH; Modugno F; Ness RB; LaMonte MJ; Friel G; Segal BH; Odunsi K; Mayor P; Zsiros E; Schmalfeldt B; Klapdor R; Dӧrk T; Hillemanns P; Kelemen LE; Kӧbel M; Steed H; de Fazio A; ; Jordan SJ; Nagle CM; Risch HA; Rossing MA; Doherty JA; Goodman MT; Edwards R; Matsuo K; Mizuno M; Karlan BY; Kjær SK; Høgdall E; Jensen A; Schildkraut JM; Terry KL; Cramer DW; Bandera EV; Paddock LE; Kiemeney LA; Massuger LF; Kupryjanczyk J; Berchuck A; Chang-Claude J; Diergaarde B; Webb PM; Moysich KB;
    Cancer Causes Control; 2017 May; 28(5):469-486. PubMed ID: 28293802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone Prevents High-Grade Serous Ovarian Cancer by Inducing Necroptosis of p53-Defective Fallopian Tube Epithelial Cells.
    Wu NY; Huang HS; Chao TH; Chou HM; Fang C; Qin CZ; Lin CY; Chu TY; Zhou HH
    Cell Rep; 2017 Mar; 18(11):2557-2565. PubMed ID: 28297660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
    Phelan CM; Kuchenbaecker KB; Tyrer JP; Kar SP; Lawrenson K; Winham SJ; Dennis J; Pirie A; Riggan MJ; Chornokur G; Earp MA; Lyra PC; Lee JM; Coetzee S; Beesley J; McGuffog L; Soucy P; Dicks E; Lee A; Barrowdale D; Lecarpentier J; Leslie G; Aalfs CM; Aben KKH; Adams M; Adlard J; Andrulis IL; Anton-Culver H; Antonenkova N; ; Aravantinos G; Arnold N; Arun BK; Arver B; Azzollini J; Balmaña J; Banerjee SN; Barjhoux L; Barkardottir RB; Bean Y; Beckmann MW; Beeghly-Fadiel A; Benitez J; Bermisheva M; Bernardini MQ; Birrer MJ; Bjorge L; Black A; Blankstein K; Blok MJ; Bodelon C; Bogdanova N; Bojesen A; Bonanni B; Borg Å; Bradbury AR; Brenton JD; Brewer C; Brinton L; Broberg P; Brooks-Wilson A; Bruinsma F; Brunet J; Buecher B; Butzow R; Buys SS; Caldes T; Caligo MA; Campbell I; Cannioto R; Carney ME; Cescon T; Chan SB; Chang-Claude J; Chanock S; Chen XQ; Chiew YE; Chiquette J; Chung WK; Claes KBM; Conner T; Cook LS; Cook J; Cramer DW; Cunningham JM; D'Aloisio AA; Daly MB; Damiola F; Damirovna SD; Dansonka-Mieszkowska A; Dao F; Davidson R; DeFazio A; Delnatte C; Doheny KF; Diez O; Ding YC; Doherty JA; Domchek SM; Dorfling CM; Dörk T; Dossus L; Duran M; Dürst M; Dworniczak B; Eccles D; Edwards T; Eeles R; Eilber U; Ejlertsen B; Ekici AB; Ellis S; Elvira M; ; Eng KH; Engel C; Evans DG; Fasching PA; Ferguson S; Ferrer SF; Flanagan JM; Fogarty ZC; Fortner RT; Fostira F; Foulkes WD; Fountzilas G; Fridley BL; Friebel TM; Friedman E; Frost D; Ganz PA; Garber J; García MJ; Garcia-Barberan V; Gehrig A; ; Gentry-Maharaj A; Gerdes AM; Giles GG; Glasspool R; Glendon G; Godwin AK; Goldgar DE; Goranova T; Gore M; Greene MH; Gronwald J; Gruber S; Hahnen E; Haiman CA; Håkansson N; Hamann U; Hansen TVO; Harrington PA; Harris HR; Hauke J; ; Hein A; Henderson A; Hildebrandt MAT; Hillemanns P; Hodgson S; Høgdall CK; Høgdall E; Hogervorst FBL; Holland H; Hooning MJ; Hosking K; Huang RY; Hulick PJ; Hung J; Hunter DJ; Huntsman DG; Huzarski T; Imyanitov EN; Isaacs C; Iversen ES; Izatt L; Izquierdo A; Jakubowska A; James P; Janavicius R; Jernetz M; Jensen A; Jensen UB; John EM; Johnatty S; Jones ME; Kannisto P; Karlan BY; Karnezis A; Kast K; ; Kennedy CJ; Khusnutdinova E; Kiemeney LA; Kiiski JI; Kim SW; Kjaer SK; Köbel M; Kopperud RK; Kruse TA; Kupryjanczyk J; Kwong A; Laitman Y; Lambrechts D; Larrañaga N; Larson MC; Lazaro C; Le ND; Le Marchand L; Lee JW; Lele SB; Leminen A; Leroux D; Lester J; Lesueur F; Levine DA; Liang D; Liebrich C; Lilyquist J; Lipworth L; Lissowska J; Lu KH; Lubinński J; Luccarini C; Lundvall L; Mai PL; Mendoza-Fandiño G; Manoukian S; Massuger LFAG; May T; Mazoyer S; McAlpine JN; McGuire V; McLaughlin JR; McNeish I; Meijers-Heijboer H; Meindl A; Menon U; Mensenkamp AR; Merritt MA; Milne RL; Mitchell G; Modugno F; Moes-Sosnowska J; Moffitt M; Montagna M; Moysich KB; Mulligan AM; Musinsky J; Nathanson KL; Nedergaard L; Ness RB; Neuhausen SL; Nevanlinna H; Niederacher D; Nussbaum RL; Odunsi K; Olah E; Olopade OI; Olsson H; Olswold C; O'Malley DM; Ong KR; Onland-Moret NC; ; Orr N; Orsulic S; Osorio A; Palli D; Papi L; Park-Simon TW; Paul J; Pearce CL; Pedersen IS; Peeters PHM; Peissel B; Peixoto A; Pejovic T; Pelttari LM; Permuth JB; Peterlongo P; Pezzani L; Pfeiler G; Phillips KA; Piedmonte M; Pike MC; Piskorz AM; Poblete SR; Pocza T; Poole EM; Poppe B; Porteous ME; Prieur F; Prokofyeva D; Pugh E; Pujana MA; Pujol P; Radice P; Rantala J; Rappaport-Fuerhauser C; Rennert G; Rhiem K; Rice P; Richardson A; Robson M; Rodriguez GC; Rodríguez-Antona C; Romm J; Rookus MA; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Salvesen HB; Sandler DP; Schoemaker MJ; Senter L; Setiawan VW; Severi G; Sharma P; Shelford T; Siddiqui N; Side LE; Sieh W; Singer CF; Sobol H; Song H; Southey MC; Spurdle AB; Stadler Z; Steinemann D; Stoppa-Lyonnet D; Sucheston-Campbell LE; Sukiennicki G; Sutphen R; Sutter C; Swerdlow AJ; Szabo CI; Szafron L; Tan YY; Taylor JA; Tea MK; Teixeira MR; Teo SH; Terry KL; Thompson PJ; Thomsen LCV; Thull DL; Tihomirova L; Tinker AV; Tischkowitz M; Tognazzo S; Toland AE; Tone A; Trabert B; Travis RC; Trichopoulou A; Tung N; Tworoger SS; van Altena AM; Van Den Berg D; van der Hout AH; van der Luijt RB; Van Heetvelde M; Van Nieuwenhuysen E; van Rensburg EJ; Vanderstichele A; Varon-Mateeva R; Vega A; Edwards DV; Vergote I; Vierkant RA; Vijai J; Vratimos A; Walker L; Walsh C; Wand D; Wang-Gohrke S; Wappenschmidt B; Webb PM; Weinberg CR; Weitzel JN; Wentzensen N; Whittemore AS; Wijnen JT; Wilkens LR; Wolk A; Woo M; Wu X; Wu AH; Yang H; Yannoukakos D; Ziogas A; Zorn KK; Narod SA; Easton DF; Amos CI; Schildkraut JM; Ramus SJ; Ottini L; Goodman MT; Park SK; Kelemen LE; Risch HA; Thomassen M; Offit K; Simard J; Schmutzler RK; Hazelett D; Monteiro AN; Couch FJ; Berchuck A; Chenevix-Trench G; Goode EL; Sellers TA; Gayther SA; Antoniou AC; Pharoah PDP
    Nat Genet; 2017 May; 49(5):680-691. PubMed ID: 28346442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.
    Davies H; Glodzik D; Morganella S; Yates LR; Staaf J; Zou X; Ramakrishna M; Martin S; Boyault S; Sieuwerts AM; Simpson PT; King TA; Raine K; Eyfjord JE; Kong G; Borg Å; Birney E; Stunnenberg HG; van de Vijver MJ; Børresen-Dale AL; Martens JW; Span PN; Lakhani SR; Vincent-Salomon A; Sotiriou C; Tutt A; Thompson AM; Van Laere S; Richardson AL; Viari A; Campbell PJ; Stratton MR; Nik-Zainal S
    Nat Med; 2017 Apr; 23(4):517-525. PubMed ID: 28288110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancer: Algorithm enables early detection.
    Sidaway P
    Nat Rev Clin Oncol; 2017 May; 14(5):262. PubMed ID: 28290491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.